PharmaCyte Biotech, Inc. (PMCB): auditor change — PharmaCyte Biotech auditor Marcum resigns, replaced by CBIZ CPAs P.C.; material weaknesses reiterated

PharmaCyte Biotech, Inc.

Marcum LLP resigned as independent auditor on Feb 21, 2025, effective upon CBIZ CPAs P.C. acquiring Marcum's attest business.
Audit Committee immediately engaged CBIZ CPAs P.C. as successor independent registered public accounting firm.
No disagreements with Marcum on accounting principles or audit scope during FYE April 30, 2024 or interim period.
Material weaknesses disclosed in prior 10-K remain: insufficient segregation of CFO duties and insufficient management review controls.
Marcum provided letter to SEC agreeing with the company's statements regarding the change.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Marcum LLP resigned as auditor of PharmaCyte Biotech, Inc..

Action: resignation
Auditor: Marcum LLP
Successor: CBIZ CPAs P.C.

Exact text from the filing

(the “Company”) was notified by Marcum LLP (“Marcum”) that Marcum resigned as the independent registered accounting firm of the Company. Based on information provided by Marcum, effective November 1, 2024, CBIZ CPAs P.C. acquired the attest business of Marcum. On February 21, 2025, the Audit Committee of the Company’s Board of Directors accepted the resignation of Marcum and approved the engagement of CBIZ CPAs P.C.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

PharmaCyte Biotech, Inc. engaged CBIZ CPAs P.C. as its auditor.

Action: engagement
Auditor: CBIZ CPAs P.C.

Exact text from the filing

On February 21, 2025, the Audit Committee of the Company’s Board of Directors accepted the resignation of Marcum and approved the engagement of CBIZ CPAs P.C. to serve as the Company’s independent registered public accounting firm.

View on SEC.gov

8 auditor changes filed in the last 30 days. Browse all auditor changes →

PharmaCyte Biotech, Inc. filing history →

Source: SEC EDGAR

accession 0001683168-25-001236

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.